Pharmaceuticals, Biotechnology and Life Sciences
The European Commission has approved two of Celgene’s IMiD®-based combination regimens: REVLIMID in combination with bortezomib and dexamethasone (RVd) in…
A major step towards clinical trials PARIS–(BUSINESS WIRE)–PEP-Therapy, a biotechnology company developing peptides as targeted therapies for oncology, announces that…
BRISBANE, Calif.–(BUSINESS WIRE)–Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing treatments for life-threatening food allergies, today announced that its Chief…
Trudy H. Grossman, Ph.D., and Roger Léger, Ph.D., named to executive leadership positions FARMINGTON, Conn.–(BUSINESS WIRE)–Azitra, Inc., a clinical-stage medical…
MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., is proud to announce that…
– Company Enters into Commercial Supply Agreement for AR101 – BRISBANE, Calif.–(BUSINESS WIRE)–Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company…
New Category Offers Surgeons Strong, Secure Fixation and “Biologically Friendly” Approach to Restoring Patient Stability and Mobility with No Permanent…
PRINCETON, N.J.–(BUSINESS WIRE)–Certara® the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, announced today…
–Company strengthens board of directors and scientific advisory board with appointments of Mike Raab and Benjamin Cravatt– SAN FRANCISCO–(BUSINESS WIRE)–Tempest…
̶ ICON-2 program targets Tissue Factor (TF) with potential broad impact in oncology ̶ ̶ Exelixis will make upfront payment…